MIMETAS - Human Tissue Models for Better Therapies

Human tissue and disease models for better, more reliable, and tailored medicines

MIMETAS develops human tissue and disease models for better, more reliable, and tailored medicines. A significant gap exists between the predictive value of various in vitro and animal screening models and a patient. MIMETAS fills this gap with its OrganoPlate® featuring organotypic screening models that have improved predictability and can be screened at high throughput.

MIMETAS' OrganoPlate® serves as an early stage screening model to predict toxic side effects and drug efficacy. The OrganoPlate® is a microfluidics‐based, advanced 3D tissue culture platform that enables culturing and screening of a range of human tissue and disease models that have a better predictive value than currently available approaches. The platform is compatible with standard robot and readout equipment, making the technology prone to high‐throughput automation.